| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Centre d’Evaluation et de Traitement de la Douleur et Département d’Anesthésiologie (Drs. Attal, Guirimand, Brasseur, Chauvin, Bouhassira, and V. Gaude), and Hôpital Ambroise Paré, Boulogne, INSERM U-161 (Drs. Attal, Guirimand, Brasseur, Chauvin, and Bouhassira), Paris, France.
Address correspondence and reprint requests to Dr. Didier Bouhassira, Centre d’ Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92104 Boulogne, France; e-mail: bouhassira{at}broca.inserm.fr
Objective: To investigate the effects of IV morphine on central pain syndromes through quantitative sensory testing and to assess the long-term benefit of oral morphine.
Methods: After an initial open titration phase aiming to determine the maximal tolerated dosage of IV morphine, the efficacy of morphine infusion (9–30 mg; mean dosage, 16 mg) was assessed in a double-blind, placebo-controlled and crossover fashion in 15 patients with poststroke- (6 patients) or spinal cord injury- (9 patients) related pain. All of the patients subsequently received sustained oral morphine.
Results: Morphine significantly reduced the intensity of brush-induced allodynia but had no effect on other evoked pains (i.e., static mechanical and thermal allodynia/hyperalgesia). The effects of morphine on ongoing pain were not significantly different from those of the placebo, but 7 patients (46%) responded to morphine. There was a correlation between the effects of morphine on spontaneous pain and the decrease of the responses to suprathreshold thermal stimuli on the nonpainful contralateral side, suggesting that these effects were related to the general antinociceptive activity of the drug. The effects of IV morphine were correlated with those of oral morphine at 1 month, but only 3 patients (20%) were still taking morphine after 1 year.
Conclusions: IV morphine induces analgesic effects on some components of central neuropathic pain syndromes, but only a minority of patients may benefit from long-term opioid treatment.
This article has been cited by other articles:
|
|
 |
|
  J. C. Que, P. J. Siddall, and M. J. Cousins Pain Management in a Patient With Intractable Spinal Cord Injury Pain: A Case Report and Literature Review Anesth. Analg., November 1, 2007; 105(5): 1462 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Hains and S. G. Waxman Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., April 19, 2006; 26(16): 4308 - 4317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ducreux, N. Attal, F. Parker, and D. Bouhassira Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia Brain, April 1, 2006; 129(4): 963 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Rowbotham Mechanisms of neuropathic pain and their implications for the design of clinical trials Neurology, December 29, 2005; 65(12_suppl_4): S66 - S73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Eisenberg, E. D. McNicol, and D. B. Carr Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin: Systematic Review and Meta-analysis of Randomized Controlled Trials JAMA, June 22, 2005; 293(24): 3043 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Buntin-Mushock, L. Phillip, K. Moriyama, and P. P. Palmer Age-Dependent Opioid Escalation in Chronic Pain Patients Anesth. Analg., June 1, 2005; 100(6): 1740 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hays, C. Reid, M. Doran, and K. Geary Use of Methadone for the Treatment of Diabetic Neuropathy Diabetes Care, February 1, 2005; 28(2): 485 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Nicholson Evaluation and treatment of central pain syndromes Neurology, March 9, 2004; 62(90052): S30 - 36. [Abstract] [Full Text]
|
|
|
|
|
|
N. Attal, J. Rouaud, L. Brasseur, M. Chauvin, and D. Bouhassira Systemic lidocaine in pain due to peripheral nerve injury and predictors of response Neurology, January 27, 2004; 62(2): 218 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Canavero, V. Bonicalzi, J. K. Simpson III, and K. M. Foley Chronic Neuropathic Pain N. Engl. J. Med., June 26, 2003; 348(26): 2688 - 2689. [Full Text] [PDF]
|
|
|
|
|
|
K. M. Foley Opioids and Chronic Neuropathic Pain N. Engl. J. Med., March 27, 2003; 348(13): 1279 - 1281. [Full Text] [PDF]
|
|
|
|
|
|
T. S. Jensen and S. H. Sindrup Opioids: A way to control central pain? Neurology, February 26, 2002; 58(4): 517 - 518. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
